Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Nevro Corp
NVROCurrent price
5.53 USD
-0.07 USD (-1.25%)
Last closed
5.51 USD
Company
www.nevro.com
ISIN
US64157F1030
Sector
Healthcare
Industry
Medical Devices
Exchange
NYSE
Capitalization
182 687 488 USD
Yield for 12 month
-65.59 %
1Y
3Y
5Y
10Y
15Y
NVRO
Nevro Corp., a medical device company, engages in the provision of products for patients suffering from chronic pain in the United States and internationally. The company provides HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS implantable pulse generator (IPG) system, an evidence-based neuromodulation system for the treatment of chronic back and leg pain through paresthesia-free 10 kHz therapy, as well as offers Senza II and Senza Omnia SCS IPG systems. It also offers Senza HFX iQ platform, that includes HFX iQ implantable pulse generator, HFX trial stimulator, and HFX iQ patient remote, as well as HFX App, a patient remote control and the wireless trialing system; and provides sacroiliac joint fusion devices under NevroV1, NevroFix, and NevroPro brands. In addition, the company offers surpass surgical and percutaneous leads. It sells its products through its direct sales force, and a network of sales agents and independent distributors. The company was incorporated in 2006 and is headquartered in Redwood City, California. Address: 1800 Bridge Parkway, Redwood City, CA, United States, 94065
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
9.79 USDP/E ratio
–Dividend Yield
–Current Year
+425 174 000 USD
Last Year
+406 365 000 USD
Current Quarter
+104 161 000 USD
Last Quarter
+101 899 000 USD
Current Year
+278 525 000 USD
Last Year
+276 367 000 USD
Current Quarter
+63 896 000 USD
Last Quarter
+67 559 000 USD
Key Figures NVRO
1 year
3 years
5 years
10 years
EBITDA
-84 492 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-10 %
PEG Ratio
-3.13
Return On Equity TTM
-27.22 %
Wall Street Target Price
9.79 USD
Revenue TTM
426 097 984 USD
Book Value
7.37 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-4.3 %
Dividend Yield
–
Gross Profit TTM
276 367 000 USD
Earnings per share
-2.12 USD
Diluted Eps TTM
-2.12 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-18.18 %
Dividend Analytics NVRO
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History NVRO
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:24
Payout Ratio
–
Last Split Date
06.11.2014
Dividend Date
–
Stock Valuation NVRO
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
0.327
Price Sales TTM
0.4287
Enterprise Value EBITDA
-4.7877
Price Book MRQ
0.6226
Financials NVRO
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators NVRO
For 52 weeks
4.38 USD
22.64 USD
50 Day MA
5.32 USD
Shares Short Prior Month
2 927 097
200 Day MA
10.41 USD
Short Ratio
7.25
Shares Short
3 130 797
Short Percent
9.68 %
BeatStart